Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.30
-2.38%
Mkt Cap $855.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+97.7%
Consensus $8.50 vs current $4.30
NASDAQ·Healthcare·Biotechnology
$4.30
-2.38%
Mkt Cap $855.34M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+97.7%
Consensus $8.50 vs current $4.30